Santhera Pharmaceuticals Holding AG ( SPHDF) - Key Metrics
Stock symbol SPHDF is outdated, potentially delisted? Maybe it is available on other exchange?
SPHDF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $3.97 | -$0.78 | -$1.06 | -$1.06 |
| 2025Q2 | $1.88 | -$3.04 | -$1.61 | -$1.62 |
| 2024Q4 | $2.19 | -$2.34 | -$1.78 | -$1.78 |
| 2024Q2 | $1.25 | -$1.35 | -$1.35 | -$1.35 |
| 2023Q4 | $8.91 | $7 | $5.61 | $5.60 |
SPHDF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | 0% | -3.39 |
| 2025Q2 | 0% | -0.96 |
| 2024Q4 | 0% | -0.91 |
| 2024Q2 | 0% | -1.95 |
| 2023Q4 | 0% | 0.35 |
SPHDF
Price: $19.79
52 week price:
Earnings Per Share: -4.79 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 344.8 million